Genetic alteration analysis showed that APC, TP53, TTN, KRAS, SYNE1, MUC16, PIK3CA, FAT4, RYR2 and OBSCN were the mutation rates of the top 10 genes in CRC patients (Figure 6A). This evidence concerns the gene KRAS and colorectal carcinoma.